Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 2
1989 3
1990 3
1991 11
1992 13
1993 4
1994 5
1995 5
1996 3
1997 7
1998 4
1999 6
2000 4
2001 9
2002 11
2003 10
2004 11
2005 24
2006 19
2007 16
2008 12
2009 14
2010 15
2011 14
2012 17
2013 15
2014 19
2015 23
2016 11
2017 12
2018 17
2019 6
2020 15
2021 16
2022 18
2023 16
2024 17
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Results by year

Filters applied: . Clear all
Page 1
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. N Engl J Med. 2025 Mar 27;392(12):1168-1177. doi: 10.1056/NEJMoa2409712. Epub 2024 Nov 14. N Engl J Med. 2025. PMID: 39541094 Clinical Trial.
Development of an algorithm for IgG4-related disease management.
Orozco-Gálvez O, Fernández-Codina A, Lanzillotta M, Ebbo M, Schleinitz N, Culver EL, Rebours V, D'Cruz DP, Della-Torre E, Martínez-Valle F. Orozco-Gálvez O, et al. Among authors: d cruz dp. Autoimmun Rev. 2023 Mar;22(3):103273. doi: 10.1016/j.autrev.2023.103273. Epub 2023 Jan 20. Autoimmun Rev. 2023. PMID: 36682575 Review.
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Houssiau FA, et al. Among authors: d cruz d. Arthritis Rheum. 2002 Aug;46(8):2121-31. doi: 10.1002/art.10461. Arthritis Rheum. 2002. PMID: 12209517 Clinical Trial.
Lupus enteritis: a narrative review.
Muñoz-Urbano M, Sangle S, D'Cruz DP. Muñoz-Urbano M, et al. Among authors: d cruz dp. Rheumatology (Oxford). 2024 May 3;63(6):1494-1501. doi: 10.1093/rheumatology/kead689. Rheumatology (Oxford). 2024. PMID: 38216993 Review.
Pulmonary Complications of Systemic Lupus Erythematosus.
Hannah JR, D'Cruz DP. Hannah JR, et al. Among authors: d cruz dp. Semin Respir Crit Care Med. 2019 Apr;40(2):227-234. doi: 10.1055/s-0039-1685537. Epub 2019 May 28. Semin Respir Crit Care Med. 2019. PMID: 31137062 Free article. Review.
Rheumatology.
Asherson RA, Cervera R, D'Cruz DP, Hughes GR. Asherson RA, et al. Among authors: d cruz dp. Postgrad Med J. 1991 Feb;67(784):114-39. doi: 10.1136/pgmj.67.784.114. Postgrad Med J. 1991. PMID: 2041842 Free PMC article. Review. No abstract available.
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Merrill JT, Tanaka Y, D'Cruz D, Vila-Rivera K, Siri D, Zeng X, Saxena A, Aringer M, D'Silva KM, Cheng L, Mohamed MF, Siovitz L, Bhatnagar S, Gaudreau MC, Doan TT, Friedman A. Merrill JT, et al. Among authors: d cruz d. Arthritis Rheumatol. 2024 Oct;76(10):1518-1529. doi: 10.1002/art.42926. Epub 2024 Aug 7. Arthritis Rheumatol. 2024. PMID: 38923871 Clinical Trial.
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Gordon C, et al. Among authors: d cruz d. Rheumatology (Oxford). 2018 Jan 1;57(1):e1-e45. doi: 10.1093/rheumatology/kex286. Rheumatology (Oxford). 2018. PMID: 29029350 Free article. No abstract available.
409 results